Companies: 10,795·Total market cap: $144.5T
Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc.

FUSNNASDAQHealthcare
$21.55
+$0.03(+0.14%)
Market Cap$1.8B
P/E Ratio—
52W High$21.6
52W Low$2.31
Overview
Foreign Private Issuer · Files 20-F / 6-K

Fusion Pharmaceuticals Inc. (FUSN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001805890 · FUSN · NASDAQ · as of Jun 8, 2026

Filing snapshot

293
Total Filings
15-12G
Latest Form
2024-06-17
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001805890 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-04-12
Fiscal Year End
Apr 12, 2024
Accession No.
0000950170-24-043865
Primary Document
fusn-20231231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001805890 · Accession 0000950170-24-043865

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
8-K
2024-06-04Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2024-06-17
View
EFFECTEFFECT
EFFECT
2024-06-07
View
EFFECTEFFECT
EFFECT
2024-06-07
View
EFFECTEFFECT
EFFECT
2024-06-07
View
25-NSE25-NSE
25-NSE
2024-06-05
View
POS AMPOS AM
POS AM
2024-06-04
View
POS AMPOS AM
POS AM
2024-06-04
View
POS AMPOS AM
POS AM
2024-06-04
View
S-8 POSS-8 POS
S-8 POS
2024-06-04
View
S-8 POSS-8 POS
S-8 POS
2024-06-04
View
S-8 POSS-8 POS
S-8 POS
2024-06-04
View
S-8 POSS-8 POS
S-8 POS
2024-06-04
View
S-8 POSS-8 POS
S-8 POS
2024-06-04
View
8-KCurrent Report
8-K
2024-06-04
View
8-KCurrent Report
8-K
2024-05-31
View
Showing 1–15 of 183 filingsForm 4 / 144 hidden· 293 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001805890  |  Exchange: NASDAQ · Healthcare

Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) has submitted 293 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001805890, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Fusion Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Fusion Pharmaceuticals Inc. 10-K was filed on 2024-04-12 for fiscal year ending 2024. Historical FUSN 10-K annual reports are available from 2020 through 2024.

Investors researching Fusion Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
PRVB SEC Filings →LBPH SEC Filings →DICE SEC Filings →ASTH SEC Filings →BLU SEC Filings →AMAM SEC Filings →PNT SEC Filings →CINC SEC Filings →
→ FUSN Financials→ FUSN Earnings→ FUSN Insider Trades

Frequently Asked Questions

FUSN SEC Filings · 8 questions

Fusion Pharmaceuticals Inc. (FUSN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 293 filings and access original documents at no cost. Fusion Pharmaceuticals Inc.'s CIK is 0001805890.

FUSN SEC filingsFusion Pharmaceuticals Inc. SEC documentsfind FUSN 10-K